| Income Statement | 2026-04-30 | |||
|---|---|---|---|---|
| Marketing and advertising expense | 9,256 | |||
| Depreciation, depletion and amortization, nonproduction | 11,422 | |||
| Represents bank charges | 3,644 | |||
| Business development | 85,712 | |||
| Represents consulting fee expense | 1,228,909 | |||
| Filing fee expense | 17,618 | |||
| General insurance expense | 4,148 | |||
| Represent the amount of investor relations expenses | 1,085 | |||
| Management and incentive fees expense | 609,613 | |||
| General and administrative expense | 16,867 | |||
| Consulting expenses | 325,489 | |||
| Research and development expense | 66,605 | |||
| Total operating expenses | 2,380,368 | |||
| Loss from operations | -2,380,368 | |||
| Represents the amount of gain on conversion of payables | 0 | |||
| Investment income, interest | 84,295 | |||
| Interest expense | 0 | |||
| Foreign exchange gain (loss) | -8,210 | |||
| Other nonoperating income (expense) | 76,085 | |||
| Income (loss) from continuing operations before income taxes, noncontrolling interest | -2,304,283 | |||
| Income tax expense (benefit) | 0 | |||
| Net loss | -2,304,283 | |||
| Basic EPS | -0.11 | |||
| Diluted EPS | -0.11 | |||
| Basic Average Shares | 20,569,664 | |||
| Diluted Average Shares | 20,569,664 | |||
Conexeu Sciences Inc. (CNXU)
Conexeu Sciences Inc. (CNXU)